Gsa Capital Partners LLP Oramed Pharmaceuticals Inc. Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$2.51 - $3.55 $189,939 - $268,639	-75,673 Reduced 45.97%	88,923 $232,000
Q2 2023 Aug 14, 2023	BUY	$2.12 - $4.47 $348,943 - $735,744	164,596 New	164,596 $589,000
Q4 2022 Feb 13, 2023	BUY	$5.88 - $12.03 $270,709 - $553,849	46,039 New	46,039 $554,000
Q4 2020 Feb 03, 2021	SELL	$2.48 - $4.64 $48,754 - $91,217	-19,659 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$2.58 - $4.16 $50,720 - $81,781	19,659 New	19,659 $51,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.4M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.